Alimera Sciences down on filing lawsuit against ANI Pharma to close deal
** Shares of eye drug developer Alimera Sciences ALIM.O
fall 16.67% to $4.61
** Co files lawsuit to compel ANI Pharmaceuticals ANIP.O
to close merger transaction
** The lawsuit asks the court to require ANI to comply with
its obligations to complete the transaction as contemplated by
the agreement
** The companies announced their agreement in June, valuing
ALIM at about $381 mln in upfront consideration
** ALIM up ~6% YTD
(Reporting by Sriparna Roy in Bengaluru)
((Sriparna.Roy@thomsonreuters.com;))
Recent news on ANI Pharmaceuticals
See all newsBrief: Ani Pharmaceuticals Announces The Launch Of Duloxetine Delayed-Release Capsules
Brief: Ani Pharmaceuticals Announces The FDA Approval Of Everolimus Tablets For Oral Suspension
Brief: Ani Pharmaceuticals Appoints Henry Gosebruch To Board Of Directors
U.S. RESEARCH ROUNDUP-Compass Minerals, Duke Energy, Tesla
ANI Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary